IFNG and myeloid sarcoma: In our study we found clear evidences that the two milk oligosaccharides 2’-FL and LNFP-I, used in a concentration which could be considered physiological, negatively influenced MNC activation by decreasing their proliferation in a dose-dependent fashion; 2’-FL and LNFP-I also have an inhibitory role on IFN-γ and IL-12 production in vitro, particularly in MS patients, and a pro-releasing effect on the Th2 cytokine IL-10.